Publications by authors named "S Arvind"

Primary prevention of diabetes still remains as an unmet challenge in a real world setting. While, translational programmes have been successful in the developed nations, the prevailing social and economic inequities in the low and middle income countries, fail to integrate diabetes prevention into their public health systems. The resulting exponential increase in the prevalence of diabetes and the cost of treatment has put primary prevention in the back seat.

View Article and Find Full Text PDF

The broadening in photoelectron spectra of polymers can be attributed to several factors, such as light source spread, spectrometer resolution, the finite lifetime of the hole state, and solid-state effects. Here, for the first time, we set up a computational protocol to assess the peak broadening induced for both core and valence levels by solid-state effects in four amorphous polymers by using a combination of density functional theory, many-body perturbation theory, and classical polarizable embedding. We show that intrinsic local inhomogeneities in the electrostatic environment induce a Gaussian broadening of 0.

View Article and Find Full Text PDF

Cyber-attacks on healthcare institutions have increased in recent years and have made headlines through the COVID-19 pandemic. With the fallout of attacks increasingly reported in academic research and in the media, there is a real urgency to address cyber-threats that must be augmented across and within health systems. Until now, clinical healthcare professionals have considered cyber-attacks on healthcare organisations a predominantly information and communication technology issue, but this perception is no longer fit-for-purpose.

View Article and Find Full Text PDF
Article Synopsis
  • Type 2 Diabetes Mellitus (T2DM) is increasingly becoming a major public health issue, and tailored treatment approaches are recommended for patients, especially those newly diagnosed in India with an HbA1c level above 7.5%.
  • A committee of seventeen diabetes experts assessed three key statements regarding the treatment of these patients using a 9-point Likert scale to gauge consensus.
  • The consensus was that dual therapy combining Dipeptidyl Peptidase-4 inhibitors (DPP4Is) and Metformin should be the first-line treatment for newly diagnosed Indian T2DM patients with HbA1c levels over 7.5%, as it is both effective and cost-efficient.
View Article and Find Full Text PDF